
Xiaojun Jiang
- Post doc; PhD
Education
PhD University of Science and Technology of China (USTC), 2013
Positions
2014 - present: post doc at the K.G. Jebsen Inflammation Research Centre (JIRC), affiliated with NoPSC.
Research interests
Primary sclerosing cholangitis, liver specific immune cells, innate immunity
Publications 2026
Natural Killer T cells promote cholestatic liver disease independent of antigen presentation by cholangiocytes
Hepatol Commun, 10 (2)
DOI 10.1097/HC9.0000000000000862, PubMed 41543487
Publications 2025
Multimodal transcriptomics identifies metallothionein as a novel pathway in primary sclerosing cholangitis
Hepatology (in press)
DOI 10.1097/HEP.0000000000001432, PubMed 40560681
Publications 2024
Microbial exposure during early life regulates development of bile duct inflammation
Scand J Gastroenterol, 59 (2), 192-201
DOI 10.1080/00365521.2023.2278423, PubMed 37997753
Publications 2023
Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation
Gastroenterology, 166 (4), 667-679
DOI 10.1053/j.gastro.2023.11.283, PubMed 37995866
Role of bacteria and microbial metabolites in immune modulation during early life
Scand J Immunol, 99 (2), e13336
DOI 10.1111/sji.13336, PubMed 38441196
Publications 2022
Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens
Am J Pathol, 192 (4), 629-641
DOI 10.1016/j.ajpath.2021.12.008, PubMed 35063408
Publications 2021
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Sci Transl Med, 13 (582)
DOI 10.1126/scitranslmed.abb0036, PubMed 33627483
The Role of Natural Killer Cells in Nonalcoholic Steatohepatitis: An Ongoing Debate
Cell Mol Gastroenterol Hepatol, 13 (1), 348-349
DOI 10.1016/j.jcmgh.2021.10.006, PubMed 34740615
Publications 2020
Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
Clin Exp Immunol, 203 (2), 304-314
DOI 10.1111/cei.13541, PubMed 33089489
Publications 2019
Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin
Nat Immunol, 20 (12), 1644-1655
DOI 10.1038/s41590-019-0504-0, PubMed 31636468
Publications 2018
Natural killer T cells mediate inflammation in the bile ducts
Mucosal Immunol, 11 (6), 1582-1590
DOI 10.1038/s41385-018-0066-8, PubMed 30115993
Publications 2017
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
Gut, 67 (8), 1517-1524
DOI 10.1136/gutjnl-2016-313598, PubMed 28779025
Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation
Front Immunol, 8, 765
DOI 10.3389/fimmu.2017.00765, PubMed 28713384
Genetics of primary sclerosing cholangitis and pathophysiological implications
Nat Rev Gastroenterol Hepatol, 14 (5), 279-295
DOI 10.1038/nrgastro.2016.154, PubMed 28293027
The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation
Physiol Rep, 5 (4)
DOI 10.14814/phy2.13117, PubMed 28219981